Abstract:BackgroundPrevious health economic studies recommend either a dual screening strategy [tuberculin skin test (TST) followed by interferon-γ-release assay (IGRA)] or a single one [IGRA only] for latent tuberculosis infection (LTBI), the former largely based on claims that it is more cost-effective. We sought to examine that conclusion through the use of a model that accounts for the additional costs of adverse drug reactions and directly compares two commercially available versions of the IGRA: the Quantiferon-T… Show more
“…In low-prevalence settings, the combination of TST and IGRA may be the best strategy. [51] Currently, there is little consensus on the most appropriate screening test in high-prevalence settings such as SA. [52] A patient due to commence biologic therapy should have a TST, an IGRA test (if deemed appropriate by the clinician), and a CXR.…”
“…In low-prevalence settings, the combination of TST and IGRA may be the best strategy. [51] Currently, there is little consensus on the most appropriate screening test in high-prevalence settings such as SA. [52] A patient due to commence biologic therapy should have a TST, an IGRA test (if deemed appropriate by the clinician), and a CXR.…”
“…In terms of cost, however, the TST appears best suited for the resource-strapped environment of Trinidad & Tobago (if the calculation of this variable is based mainly on the cost of the materials required to perform the test versus the cost of labor and other inputs). This argument is partly supported by Pooran et al, who concluded in a recent report that screening for LTBI using TST alone was the most cost-effective testing strategy but ultimately incurred the highest cost due to test inaccuracies [25]. Another factor that may make the TST less cost-effective over time is high replacement costs, since the Mantoux test solution is often not accessible in developing countries and would have to be replaced with the relatively labor-intensive IFN-release assay.…”
“…The combination of the TST and the QFT test could be an alternative way of improving diagnostic testing for LTBI (1,9,18,25). However, the TST itself has a poor sensitivity of 80% (17) and poor specificity among individuals vaccinated with BCG, which is the case for most HCW exposed to TB.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.